Skip to main content

Profound Medical Corp.

PROF
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001628808

No open-market purchases or sales by Profound Medical Corp. insiders were filed in the last 90 days; 55 institutions reported holding it in 13F filings for Q2 2026, worth $105.8M in total; no superinvestor holds it.

Q2 2021 vs. Q1 2021

How the institutions holding Profound Medical Corp. changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of PROF: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders5448−6
Shares8.68M8.72M+49.3K (+0.6%)
Value$174.5M$142.6M−$31.9M (−18.3%)

New holders (4)

Institutions that held Profound Medical Corp. at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to PROF in Q2 2021
InstitutionSharesValue% of portfolio
Golden State Equity Partners26,435$430.0K0.17%
MTM Investment Management, LLC17,800$290.0K0.15%
Geode Capital Management, LLC10,870$177.0K0.00%
Advisory Services Network, LLC100$2.00K0.00%

Sold out (10)

Institutions that held Profound Medical Corp. at the end of Q1 2021 and filed for Q2 2021 without it.

Institutions that sold out of PROF in Q2 2021
InstitutionShares, Q1 2021Value, Q1 2021
Parkman Healthcare Partners LLC84,399$1.70M
G2 Investment Partners Management LLC61,640$1.24M
EAM Global Investors LLC33,857$682.0K
Susquehanna International Group, LLP23,135$466.0K
Millennium Management LLC21,606$435.0K
EAM Investors, LLC10,330$208.0K
Deutsche Bank AG3,700$75.0K
BlackRock Inc.1,181$24.0K
Sowell Financial Services LLC700$14.0K
UBS Group AG300$6.00K